Learn about Avastin® (bevacizumab) solution for IV infusion, including benefits, risks, possible side effects, patient support, and options for financial help.

§§§In the Avastin IMbrave150 study, Avastin in combination with atezolizumab in patients with locally advanced unresectable and/or metastatic hepatocellular carcinoma who have not received prior …

Learn about the possible side effects of mCRC treatment with Avastin® (bevacizumab). See full safety for more information.

Learn more about Avastin® (bevacizumab) dosage and dosing schedules for approved indications. See full safety for more information.

View benefits and risks of Avastin® (bevacizumab) treatment for metastatic colorectal cancer (mCRC). See full safety for more information.

Learn more about Avastin® (bevacizumab) dosing in metastatic colorectal cancer (MCRC) treatment. See full safety for more information.

Learn more about Avastin® (bevacizumab) dosing in 1L metastatic non-squamous non-small cell lung cancer (NSCLC) treatment. See full safety for more information.

Learn more about the Avastin® (bevacizumab) important safety information. See full safety for more information.

Learn how Avastin® (bevacizumab) infusion treatments are given for patients with advanced stage III/IV ovarian cancer and recurrent platinum-treated ovarian cancer. See full safety for more information.

Learn more about Avastin® (bevacizumab) for recurrent glioblastoma (rGBM) treatment. See full safety for more information.